Interleukin-12 (IL-12)/IL-10 Ratio as a Marker of Disease Severity in Crimean-Congo Hemorrhagic Fever
- 26 April 2012
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 19 (5), 823-824
- https://doi.org/10.1128/cvi.00030-12
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remissionClinical Nutrition, 2010
- Identification of Lactobacillus plantarum genes modulating the cytokine response of human peripheral blood mononuclear cellsBMC Microbiology, 2010
- Interacting Roles of Immune Mechanisms and Viral Load in the Pathogenesis of Crimean-Congo Hemorrhagic FeverClinical and Vaccine Immunology, 2010
- From IL-10 to IL-12: how pathogens and their products stimulate APCs to induce TH1 developmentNature Immunology, 2009
- Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemiasClinical Biochemistry, 2009
- Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosisCytokine & Growth Factor Reviews, 2008
- Interleukin-10 and Interleukin-12 Modulation in Patients with Relapsing-Remitting Multiple Sclerosis on Therapy with Interferon-beta 1a: Differences in Responders and Non RespondersImmunopharmacology and Immunotoxicology, 2008
- Slower Rates of Clearance of Viral Load and Virus‐Containing Immune Complexes in Patients with Dengue Hemorrhagic FeverClinical Infectious Diseases, 2006